The use of biomarkers as a tool for novel psoriatic disease drug discovery

Dinesh Aggarwal*, Nikita Arumalla, Hannah Jethwa, Sonya Abraham

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


Introduction: Psoriatic disease is a relatively new term which encompasses psoriatic arthritis, psoriasis, and associated comorbidities. In this heterogeneous condition, the study of biomarkers is necessary to direct best therapy. Resulting in significant disability and socioeconomic burden, recent recommendations stress the need for tight control in psoriatic disease. Areas covered: The authors outline recent advances in the understanding of psoriatic disease pathogenesis which has highlighted multiple biomarkers that have been pursued as drug targets with varying degrees of success. Current drugs targeting biomarkers and therapies in development are evaluated. The methods of biomarker discovery through genomics, transcriptomics, proteomics, metabolomics, and study of the microbiome are also discussed. Expert opinion: Targeting biomarkers for therapeutic benefit appears to a promising field with multiple success stories, notably those associated with signaling through T-helper-17 cells. The use of genomics, transcriptomics, proteomics, and more recently metabolomics will help individualize targeted biomarker therapies, assist in monitoring therapeutic success, and ultimately yield novel therapeutic targets. Advances in the development of novel biologic molecules targeting more than one cytokine may offer additional gains in therapeutic response.

Original languageEnglish
Pages (from-to)875-887
Number of pages13
JournalExpert Opinion on Drug Discovery
Issue number9
Publication statusPublished - 2 Sep 2018
Externally publishedYes

Bibliographical note

Funding Information:
Merck, Sun Pharmaceutical Industries Galapagos NV AbbVie Incyte and Eli Lilly National Institutes of Health, Pfizer BASF Bioresearch Corporation, Cambridge Antibody Technology, AbbVie

Publisher Copyright:
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.


  • arthritis
  • biologics
  • biomarker
  • psoriasis
  • Psoriatic disease


Dive into the research topics of 'The use of biomarkers as a tool for novel psoriatic disease drug discovery'. Together they form a unique fingerprint.

Cite this